Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

During the Trading Day
1.78 -4.36 / -71.01%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.80 +0.02 / +1.12%
 
Volume: 36.9K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues5.4M6.8M25.8M11.0M
 
 
 
 
 
Cost of Goods Sold4.0K30.0K393.0K1.3M
 
 
 
 
 
Depreciation And Amortization40.0K45.0K49.0K43.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.4M6.8M25.4M9.6M
 
 
 
 
 
General Expenses20.6M21.2M20.1M22.8M
 
 
 
 
 
Research And Development18.5M17.1M16.5M20.1M
 
 
 
 
 
Total Operating Expenses20.6M21.3M20.5M24.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.2M-14.4M5.3M-13.2M
 
 
 
 
 
Extraordinary Credit4.8M464.0K749.0K0.00
 
 
 
 
Extraordinary Charge----0.00-452.0K
 
 
Interest Expense On Debt1.3M1.3M1.3M1.2M
 
 
 
 
 
Other Expenses0.000.000.00100.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.7M-15.2M4.9M-14.6M
 
 
 
 
 
Net Income-11.7M-15.2M4.9M-14.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.9M72.3M72.6M73.3M
 
 
 
 
 
Shares To Calculate EPS Diluted71.9M72.3M76.8M73.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.21$0.06-$0.20
 
 
 
 
 
EPS Diluted-$0.16-$0.21$0.06-$0.20